Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

New Topol book envisions patient-centered digitalized care

The good old days of "doctor knows best" are as good as gone, according to Eric Topol, renowned cardiologist at Scripps Translational Science Institute, in his new book, "The Patient Will See You Now."

Lexmark acquires Claron to expand medical content

Lexmark International has acquired Toronto-based Claron Technology, a leading provider of medical image viewing, distribution, sharing and collaboration software technology.

Thumbnail

Accenture wins $563M Healthcare.gov contract

Accenture Federal Services has won a five-year, $563 million contract to continue its work on Healthcare.gov.

Thumbnail

RWJF grant to facilitate health data sharing with researchers

Genetic Alliance, a nonprofit health advocacy organization network, has received a $500,000 grant from the Robert Wood Johnson Foundation to create and evaluate the effectiveness of a "white label" version of the Platform for Engaging Everyone Responsibly that allows individuals to share health data with researchers as they see fit.

Modernizing Medicine Closes Acquisition of Aesyntix Health, Inc.

BOCA RATON, Fla.--Modernizing Medicine, Inc., creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical records (EMR) system, announced today that it completed an acquisition of Aesyntix Health, Inc. on Dec. 22, 2014.

Thumbnail

Company contributes to Ga. Tech's interoperability lab

A national technology company has made a $40,000 donation toward Georgia Institute of Technology's Interoperability & Integration Innovation Lab (I3L), a virtual and physical laboratory for health IT.

IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit

DANBURY, Conn.--New approaches for determining how much drugs should cost, and for setting the price for innovative treatments, were highlighted in a keynote presentation by Murray Aitken, IMS Health senior vice president and executive director of the IMS Institute for Healthcare Informatics, at the Forbes Healthcare Summit held earlier this month in New York City.

Survey: U.S. consumers unaware of patient portals

More than one-third of U.S. consumers are uninformed about patient portals, according to findings in a survey conducted by Xerox.  

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.